Ocugen, Bharat Biotech to co-develop Covaxin for US

Drug developer Ocugen Inc said on Tuesday it had partnered with Bharat Biotech to co-develop the Hyderabad-based company’s Covid-19 vaccine candidate for the US market. Continue Reading

‘Covaxin is safe, trials show promising results’

Covaxin, the vaccine candidate being developed by Bharat Biotech and ICMR-National Institute of Virology, is ‘safe’ and induced ‘robust’ immune response among Phase 1 trial participants. Continue Reading

Panel to review Covid-19 vaccine applications tomorrow

An expert committee of the Central Drugs Standard Control Organisation (CDSCO) will meet on Wednesday to review applications of Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorisation for their Covid-19 vaccine candidates, official sources said. Continue Reading

Modi’s 3-city visit today to monitor Covid vaccine development

Prime Minister Narendra Modi will visit three vaccine developments sites in Ahmedabad, Hyderabad and Pune today in what is being considered as the latest fillip to India’s vaccine production. Continue Reading

Government panel meets vaccine makers in India

A Union government panel on vaccine administration for Covid-19 met representatives of leading domestic manufacturers to take inputs about the present stage of various candidate vaccines as well as their expectations from the government. Continue Reading